Renal Involvement in Monoclonal Gammopathy. (March 2015)

• Record Type: Journal Article
• Authors: Al-Hussain, Turki; Hussein, Maged H.; Al Mana, Hadeel; Akhtar, Mohammed
• Is Part Of: Advances in anatomic pathology. Volume 22:Number 2(2015)
• Publication Date: 2015-03
• Subjects: Pathology -- Periodicals; 616.0705
• DOI: 10.1097/PAP.0000000000000056
• Languages: English
• ISSNs: 1072-4109

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p>Monoclonal gammopathy is produced by neoplastic or non-neoplastic expansion of a clone of plasma cells or B lymphocytes. Monoclonal gammopathy of unknown significance is characterized by low levels of the monoclonal protein and a relatively small population of clonal lymphocytes or plasma cells in the bone marrow. In these cases, the patient is asymptomatic with no evidence of overt myeloma or lymphoma. The abnormal serum protein may be present as a complete immunoglobulin molecule or may consist of ≥1 of its components such as light chains or heavy chains. These proteins may cause a variety of diseases in various tissues and organs, of which the kidney appears to be the most vulnerable. Renal involvement in monoclonal gammopathy may occur as part of a generalized disease such as amyloidosis, immunoglobulin deposition disease, and cryoglobulinemia. In addition, there may be evidence of kidney damage by processes which are renal specific. These include light chain proximal tubulopathy, light chain cast nephropathy, and a variety of glomerulopathies encompassing a wide spectrum of disease patterns.</p> </sec> </abstract>